Metaplastic Breast Carcinoma in U.S. Population: Racial Disparities, Survival Benefit of Adjuvant Chemoradiation and Future Personalized Treatment with Genomic Landscape

SIMPLE SUMMARY: Metaplastic breast carcinoma (MBC) is a rare, heterogenous group of aggressive triple-negative breast cancers with a characteristically poor prognosis and response to standard treatments. The rarity of MBC greatly limits insight into the clinical presentation, management, and scienti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullah, Asad, Khan, Jaffar, Yasinzai, Abdul Qahar Khan, Tracy, Katharine, Nguyen, Tena, Tareen, Bisma, Garcia, Andrea Agualimpia, Heneidi, Saleh, Segura, Sheila E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251813/
https://www.ncbi.nlm.nih.gov/pubmed/37296916
http://dx.doi.org/10.3390/cancers15112954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251813/
https://www.ncbi.nlm.nih.gov/pubmed/37296916
http://dx.doi.org/10.3390/cancers15112954

Ejemplares similares